GlassScriptPhysician profile
Allison Mae Bauer
NPI 1841517901
$1,765.21
in general payments reported to CMS, 2019-2025
27 companies · $80.57 in 2025
The $80.57 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $695 · 2022: $504 · 2023: $316 · 2024: $169 · 2025: $80.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $299.91 | 2021-2025 | |
| Novo Nordisk INC | $280.46 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $191.81 | 2021-2022 | |
| Pfizer INC. | $178.24 | 2021-2022 | |
| Aimmune Therapeutics, INC. | $113.51 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.46 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.18 | 2021-2023 | Xifaxan |
| Amgen INC. | $66.64 | 2022-2023 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $65.77 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.85 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $46.90 | 2021 | |
| Medicure Pharma INC. | $35.30 | 2021 | |
| Inspire Medical Systems, INC. | $28.44 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $28.30 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $25.83 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $22.38 | 2023 | Auvelity |
| Astellas Pharma US INC | $18.97 | 2023 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $17.41 | 2022 | |
| Biogen, INC. | $17.12 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.04 | 2021 | |
| Genentech USA, INC. | $15.46 | 2021 | |
| Acadia Pharmaceuticals INC | $15.04 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.30 | 2021 | |
| Mylan Specialty L.P. | $13.98 | 2021 | |
| Exact Sciences Corporation | $13.26 | 2023 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $13.02 | 2023 | Eliquis |
| Organon LLC | $9.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.